MiMedx Group, Inc.
MDXG
$7.08
-$0.23-3.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.79% | -5.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.79% | -5.06% | |||
| Cost of Revenue | 12.82% | -2.08% | |||
| Gross Profit | 11.55% | -5.73% | |||
| SG&A Expenses | 6.97% | -1.83% | |||
| Depreciation & Amortization | 1.01% | -48.70% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.86% | -2.21% | |||
| Operating Income | 49.92% | -25.99% | |||
| Income Before Tax | 51.03% | -23.44% | |||
| Income Tax Expenses | 113.28% | -58.30% | |||
| Earnings from Continuing Operations | 36.95% | -5.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 36.95% | -5.58% | |||
| EBIT | 49.92% | -25.99% | |||
| EBITDA | 35.16% | -18.81% | |||
| EPS Basic | 36.48% | -5.73% | |||
| Normalized Basic EPS | 50.68% | -24.27% | |||
| EPS Diluted | 25.79% | -4.79% | |||
| Normalized Diluted EPS | 51.11% | -24.21% | |||
| Average Basic Shares Outstanding | 0.33% | 0.18% | |||
| Average Diluted Shares Outstanding | -0.24% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||